FactSet Research Systems Inc. FDS
Composite 63/100; the shares have moved about 50% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Its least supportive area is Income at 53 — still above average.
Quality ranks 74/100 — a moderate point in its favour. Balance-sheet strength ranks 70/100 — a moderate point in its favour. Momentum ranks 55/100 — a slight point in its favour.
Its least supportive area is Income at 53 — still above average.
What the company does FactSet Research Systems Inc. (FDS) provides financial data, analytics, and enterprise solutions to investment professionals globally. Its platform supports research, portfolio construction, risk management, and reporting workflows via desktop, cloud, and API solutions.
Key financials FDS reports strong profitability with ROE 27%, ROA 11.1%, and ROCE 23.9%. Margins are healthy: gross 51.4%, operating 30.5%, net 23.2%. Revenue grew 5.4% and EPS 11.8%, with a dividend yield of 1.5% and payout ratio 25.8%.
Stock health The stock shows mixed signals: 3-month +16.20%, 6-month +43.80%, but 12-month -14.81%. RSI(14) at 68.70 indicates near overbought conditions. Debt/equity is 0.77 with interest coverage 9.35x.
Price vs fair value FDS trades at a PREMIUM of 18.70% versus the analyst mean target of 255.06. - Recent headlines highlight strong software sector momentum (Ten large-cap financial stocks outperforming in August 2026; Another Day, Another Software Stock Surging 20%). - Analyst coverage notes bullish sentiment (FactSet Stock Outlook: Is Wall Street Bullish or Bearish?). - Dividend analysis suggests stability (FactSet Research Systems Inc's Dividend Analysis).
Looking forward Forward P/E of 14.75 and PEG of 0.41 suggest reasonable earnings growth expectations. Sideravia’s overall score of 62.3 reflects strong quality (75.2) but middling momentum (55.6) and valuation (50.5).
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.